Again, the increased IL-17A levels in the blood are linked with the aggressiveness of pancreatic adenocarcinoma, non-small cell lung cancer, thyroid tumors, laryngeal squamous cell carcinoma, and colorectal carcinoma [37–40]. This evidence concerns the gene IL17A and colorectal carcinoma.